Triple

T34091454
Position Surface form Disambiguated ID Type / Status
Subject fenfluramine E874310 entity
Predicate hasCurrentMarketingAuthorizationHolder P26890 FINISHED
Object UCB Pharma
UCB Pharma is a global biopharmaceutical company headquartered in Belgium that specializes in treatments for neurological and immunological disorders.
 E2081115 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: UCB Pharma | Statement: [fenfluramine, hasCurrentMarketingAuthorizationHolder, UCB Pharma]
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: UCB Pharma
Triple: [fenfluramine, hasCurrentMarketingAuthorizationHolder, UCB Pharma]
Generated description
UCB Pharma is a global biopharmaceutical company headquartered in Belgium that specializes in treatments for neurological and immunological disorders.
PD Predicate disambiguation gpt-5-mini-2025-08-07 
Target predicate: hasCurrentMarketingAuthorizationHolder
Context triple: [fenfluramine, hasCurrentMarketingAuthorizationHolder, UCB Pharma]
  • A. marketingAuthorisationHolder chosen
    Indicates the entity that holds the official authorization to market or sell a product, typically a medicinal or regulated product, in a given jurisdiction.
  • B. hasCurrentHolder
    Indicates that a specified entity is the present holder, possessor, or occupant of another entity (such as a position, title, asset, or object).
  • C. hasRegulatoryApproval
    Indicates that an entity has received formal authorization or clearance from a relevant regulatory authority to operate, be sold, or be used in a specified context.
  • D. hasMarketingRole
    Indicates that an entity holds a position or responsibility related to marketing activities within an organization.
  • E. hasMarketStatus
    Indicates the current commercial or trading condition of an entity, such as whether it is active, suspended, listed, or delisted in a market.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69f349a735208190a1dbfb1c2a121059 completed April 30, 2026, 12:23 p.m.
NER Named-entity recognition batch_69fdb04ed81c8190b8feea90c1c785a6 completed May 8, 2026, 9:43 a.m.
NED1 Entity disambiguation (via context triple) batch_6a36ae5c3e2c8190a64af10f5c848f3b completed June 20, 2026, 3:14 p.m.
NEDg Description generation batch_6a36af3eb7288190bee994ee99c9cb56 completed June 20, 2026, 3:18 p.m.
NED2 Entity disambiguation (via description) batch_6a36afe7a9208190952f11924f15856b completed June 20, 2026, 3:21 p.m.
PD Predicate disambiguation batch_69fda9d6c5148190a63205b6d9b0a1b4 completed May 8, 2026, 9:16 a.m.
Created at: May 1, 2026, 1:52 a.m.